Cadrenal Therapeutics, Inc. Common Stock
USD4.35
-0.35 (-7.45%)
CEO
Quang X. Pham
IPO Date
2023-01-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.71
Prev. Close
$4.70
Day Low
$4.20
Day High
$4.72
52W Low
$4.14
52W High
$15.99
Market Cap
$0.01B
Volume
0.16M
| 3,298 |
| $5.28 |
| 29 May 2026 | Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | S-Sale | Disposed | 2,989 | $4.93 |
| 26 May 2026 | Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | S-Sale | Disposed | 1,165 | $5.69 |
| 31 Dec 2025 | Szot Matthew K | Chief Financial Officer | S-Sale | Disposed | 9,933 | $6.97 |
| 3 Dec 2025 | Golden Lee Scott | director | A-Award | Acquired | 5,000 | $8.27 |
| 3 Dec 2025 | Golden Lee Scott | director | Disposed | 0 | $0.00 |
| 28 Oct 2025 | Szot Matthew K | Chief Financial Officer | S-Sale | Disposed | 1,800 | $13.99 |
| 28 Oct 2025 | Szot Matthew K | Chief Financial Officer | S-Sale | Disposed | 1,800 | $13.99 |
| 28 Oct 2025 | Pham Quang X | director, 10 percent owner, officer: CEO and Chairman | S-Sale | Disposed | 1,129 | $14.03 |